# A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

> clinical trial · VERIFIED · 2026-08-21

Status: RECRUITING · Sponsor: AbbVie · Condition: Ovarian Cancer

- Company: AbbVie
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07059845

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.